Puma biotechnology press release deals
Puma biotechnology press release deals
Puma biotechnology press release deals
Puma biotechnology press release deals
Puma biotechnology press release deals
Puma biotechnology press release deals

Puma biotechnology press release deals

Puma biotechnology press release deals, Puma biotechnology shop press release deals

$54.99

SKU: 7621895

Colour
  • Puma Biotechnology Biotechnology The Pharmaletter The Pharmaletter
  • Puma Biotechnology Reports Results of PB272 neratinib in P III NALA Trial for Patients with 2L HER2 Metastatic Breast Cancer ASCO2019
  • A New Drug on the Horizon for HER2 Breast Cancer Patients Avise Analytics
  • Puma Biotechnology Inc. SEC Filings Annual Reports Proxies
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus